Latest AI and machine learning research in other cancers for healthcare professionals.
Using methylation characteristics of human genes to construct machine learning predictive models fo...
Neurofibromatosis Type 1 is a genetic disorder characterized by the development of neurofibromas (...
Nasopharyngeal carcinoma (NPC) patients often undergo radiotherapy and chemotherapy, which can lea...
Based on global genomic status, the cancer tumor is classified as Microsatellite Instable (MSI) an...
Hematological malignancy is a highly heterogeneous disease with complex biological characteristics a...
Prostate cancer (Pca) continues to be a leading cause of cancer-related mortality in men, and the ...
Motivation: An adjuvant is a chemical incorporated into vaccines that enhances their efficacy by i...
Omics fusion has emerged as a crucial preprocessing approach in the field of medical image process...
Bias and inequity in palliative care disproportionately affect marginalised groups. Large language...
Cancer evolves continuously over time through a complex interplay of genetic, epigenetic, microenv...
Artificial intelligence-assisted imaging analysis has made substantial strides in tumor diagnosis ...
Neoadjuvant chemotherapy (NAC) has become a standard clinical practice for tumor downsizing in bre...
Hepatocellular carcinoma (HCC), ranking as the third leading cause of cancer-related mortality wor...
BACKGROUND: The objective of this study was to develop and validate a radiomics-based machine learni...
This study proposes a new loss function for deep neural networks, L1-weighted Dice Focal Loss (L1D...
The exploration of cellular heterogeneity within the tumor microenvironment (TME) via single-cell ...
Segmentation of brain tumors is a critical step in treatment planning, yet manual segmentation is ...
The ability of tumors to evolve and adapt by developing subclones in different genetic and epigene...
The vast majority of real-world patient information resides in unstructured clinical text, and the...
Cancer of unknown primary (CUP) constitutes between 2% and 5% of human malignancies and is among the...
IMPORTANCE: Only a small fraction of patients with advanced non-small cell lung cancer (NSCLC) respo...